Literature DB >> 278997

Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytes.

J K Czop, D T Fearon, K F Austen.   

Abstract

Monolayers of human peripheral blood monocytes in the absence of exogenous proteins ingest a variety of natural particulate activators of the human alternative complement pathway. Sheep erythrocytes, which do not ordinarily activate the human alternative complement pathway or initiate a direct monocyte phagocytic response, can be modified to exhibit both functions by the deletion or alteration of membrane sialic acid residues. Enzymatic removal of the sialic acid residues with sialidase or their conversion to heptulosonic acid derivatives by limited oxidation with NaIO4 and reduction with BH4- have equivalent dose-response effects on the capacity of the altered sheep erythrocytes to initiate the phagocytic response by human monocytes or to activate the alternative pathway in human serum. The deposition of C3b on native sheep erythrocytes had little effect on their ingestion by human monocytes, whereas the fixation of C3b on desialated sheep erythrocytes had a synergistic effect on the percentage of monocytes ingesting such a particle. The monocyte receptor essential for ingestion of desialated sheep erythrocytes or desialated sheep erythrocytes bearing C3b was inactivated by concentrations of trypsin that also prevented the monocytes from ingesting natural activators of the human alternative complement pathway, but did not alter the receptors for C3b or the Fc portion of IgG. The capacity of the nonimmune host to respond to desialated particles by initiating the monocyte ingestive process and by activating the alternative complement pathway to provide the synergy afforded by C3b deposition on that particle represents a primitive biochemical basis for differentiation of nonself from self.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 278997      PMCID: PMC392881          DOI: 10.1073/pnas.75.8.3831

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

Review 2.  CELL WALL OF YEASTS.

Authors:  H J PHAFF
Journal:  Annu Rev Microbiol       Date:  1963       Impact factor: 15.500

3.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

4.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytes.

Authors:  J K Czop; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

6.  Effect of sialidase on the viability of erythrocytes in circulation.

Authors:  D Aminoff; W C Bell; I Fulton; N Ibgebrigtsen
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

7.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

8.  Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

9.  The role of membrane receptors for C3b and C3d in phagocytosis.

Authors:  A G Ehlenberger; V Nussenzweig
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.

Authors:  D T Fearon; K F Austen
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Fibronectin and phagocytosis.

Authors:  H Hörmann
Journal:  Blut       Date:  1985-11

2.  Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis.

Authors:  R G Morris; A D Hargreaves; E Duvall; A H Wyllie
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

Review 3.  Endocytosis: a review of mechanisms and plasma membrane dynamics.

Authors:  J M Besterman; R B Low
Journal:  Biochem J       Date:  1983-01-15       Impact factor: 3.857

4.  Ganglioside receptor of rat macrophages. Modulation by enzyme treatment and evidence for its protein nature.

Authors:  G Boltz-Nitulescu; B Ortel; M Riedl; O Förster
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

5.  Saccharides mediate the attachment of rat macrophages to bone in vitro.

Authors:  Z Bar-Shavit; S L Teitelbaum; A J Kahn
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

6.  Inhibition of phagocytosis by erythrocyte membrane sialoglycoprotein on target liposomes.

Authors:  S Utsumi; H Shinomiya; J Minami; S Sonoda
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

7.  Presence of bacterial binding 'lectin-like' receptors on phagocytes.

Authors:  E Glass; J Stewart; D M Weir
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

8.  Cellular myeloperoxidase activity in human monocytes stimulated by hyposialylated immunoglobulins and rheumatoid factors.

Authors:  M D Dodon; L Gazzolo; G A Quash
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

9.  Parallelism between regulatory effects of erythrocyte glycoproteins on phagocytosis and on the alternative complement pathway.

Authors:  H Shinomiya; T Sukegawa; M Hatanaka; S Utsumi
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

10.  Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).

Authors:  N P Hurst; G Nuki; T Wallington
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.